Encore Capital Group Announces Fourth Quarter and Full-Year 2016 Financial Results
Feb 23, 2017 21:06 pm UTC| Business
Fourth quarter deployments of $210 million worldwide included $148 million in the U.S.Estimated Remaining Collections increased to $5.8 billionEncore and J.C. Flowers exploring a potential Cabot IPO SAN DIEGO, Feb. 23,...
Encore Capital Group Announces Fourth Quarter and Full-Year 2016 Financial Results
Feb 23, 2017 21:06 pm UTC| Business
Fourth quarter deployments of $210 million worldwide included $148 million in the U.S.Estimated Remaining Collections increased to $5.8 billionEncore and J.C. Flowers exploring a potential Cabot IPO SAN DIEGO, Feb. 23,...
Feb 23, 2017 21:06 pm UTC| Business
ROSEMONT, Ill., Feb. 23, 2017 -- Wintrust Financial Corporation (“Wintrust” or the “Company”) (Nasdaq:WTFC) will present at the RBC Capital Markets Financial Institutions Conference to be held in New York on March 7-8,...
Feb 23, 2017 21:06 pm UTC| Business
ROSEMONT, Ill., Feb. 23, 2017 -- Wintrust Financial Corporation (“Wintrust” or the “Company”) (Nasdaq:WTFC) will present at the RBC Capital Markets Financial Institutions Conference to be held in New York on March 7-8,...
AV Homes Reports Results for Fourth Quarter and Full Year 2016
Feb 23, 2017 21:06 pm UTC| Business
Fourth Quarter 2016 Highlights - as compared to the prior year fourth quarter (unless otherwise noted) Earnings per share increased 5% to $0.68, on net income of $17.1 million Total revenue increased 16% to $261.7...
AV Homes Reports Results for Fourth Quarter and Full Year 2016
Feb 23, 2017 21:06 pm UTC| Business
Fourth Quarter 2016 Highlights - as compared to the prior year fourth quarter (unless otherwise noted) Earnings per share increased 5% to $0.68, on net income of $17.1 million Total revenue increased 16% to $261.7...
Five Prime Announces Fourth Quarter and Full Year 2016 Financial Results
Feb 23, 2017 21:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2017 -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics,...